These results were confirmed in a larger follicular lymphoma patient cohort treated with rituximab as monotherapy and an association of the FcγRIIIa-158V/V genotype with progression-free survival could be shown (Weng and Levy, 2003). Here, FCGR3A is linked to follicular lymphoma.